Local fluorouracil chemotherapy interferes with neural and behavioral recovery after brain tumor-like mass compression

Behavioural Brain Research

Volumn 172, Issue 1, 2006, Pages 80-89

  Yang, Hongyan ^a,c   Zhang, Xuepeng ^c   Chopp, Michael ^c,d   Jiang, Feng ^c   Schallert, Timothy ^a,b,c  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d OAKLAND UNIVERSITY   (United States)

Author keywords

Behavior; Brain tumor; Chemotherapy; Injury; Recovery of function

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR DISORDER; BRAIN CORTEX; BRAIN FUNCTION; BRAIN INJURY; BRAIN NECROSIS; BRAIN REGION; BRAIN TUMOR; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FORELIMB; HEMISPHERE; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; SENSORIMOTOR CORTEX;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BEHAVIOR, ANIMAL; BRAIN; BRAIN NEOPLASMS; EVOKED POTENTIALS, SOMATOSENSORY; FLUOROURACIL; FORELIMB; FUNCTIONAL LATERALITY; IN SITU NICK-END LABELING; MALE; MOTOR CORTEX; NEURONAL PLASTICITY; PARAFFIN EMBEDDING; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSENSORY CORTEX; VIBRISSAE;

EID: 33646548393     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.04.023     Document Type: Article

References (55)

1. Akiba T., Okeda R., and Tajima T. Metabolites of 5-fluorouracil, alpha-fluoro-beta-alanine and fluoroacetic acid, directly injure myelinated fibers in tissue culture. Acta Neuropathol (Berl) 92 (1996) 8-13
2. Arrieta O., Guevara P., Escobar E., Garcia-Navarrete R., Pineda B., and Sotelo J. Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. Br J Cancer 92 (2005) 1247-1252
3. Barbieux C., Patri B., Cerf I., and De Parades V. Acute cerebellar syndrome after treatment with 5-fluorouracil. Bull Cancer 83 (1996) 77-80
4. Bellail A.C., Hunter S.B., Brat D.J., Tan C., and Van Meir E.G. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36 (2004) 1046-1069
5. Bofill J.S., Chaves M., and Moreno J.A. Fluorouracil-induced aphasia. Ann Pharmacother 34 (2000) 955
6. Bygrave H.A., Geh J.I., Jani Y., and Glynne-Jones R. Neurological complications of 5-fluorouracil chemotherapy: case report and review of the literature. Clin Oncol (R Coll Radiol) 10 (1998) 334-336
7. Chao J.Y., Wei L., Yin K., Lin T.N., and Hsu C.Y. Angiogenesis after experimental cerebral ischemia-reperfusion. In: Krieglstein J., and Klumpp S. (Eds). Pharmacology of Cerebral Ischemia (2002), Medpharm Scientific Publishers, Stuttgart 131-140
8. Chen J., Zhang Z.G., Li Y., Wang Y., Wang L., Jiang H., et al. Statins induce angiogenesis, neurogenesis and synaptogenesis after stroke. Ann Neurol 53 (2003) 743-751
9. Chen J.R., Wang Y.J., and Tseng G.F. The effect of epidural compression on cerebral cortex: a rat model. J Neurotrauma 20 (2003) 767-780
10. Chen J.R., Wang Y.J., and Tseng G.F. The effects of decompression and exogenous NGF on compressed cerebral cortex. J Neurotrauma 21 (2004) 1640-1651
11. Chung W.J., Lyons S.A., Nelson G.M., Hamza H., Gladson C.L., Gillespie G.Y., et al. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci 25 (2005) 7101-7110
12. Cramer S.C., and Chopp M. Recovery recapitulates ontogeny. Trends Neurosci 23 (2000) 265-271
13. Eberhart C.G., Kaufman W.E., Tihan T., and Burger P.C. Apoptosis, neuronal maturation, and neurotrophin expression within medulloblastoma nodules. J Neuropathol Exp Neurol 60 (2001) 462-469
14. Elkiran E.T., Altundag K., Beyazit Y., Guler N., and Kars A. Fluorouracil-induced neurotoxicity presenting with generalized tonic-clonic seizure. Ann Pharmacother 38 (2004) 2171
15. Figueredo A.T., Fawcet S.E., Molloy D.W., Dobranowski J., and Paulseth J.E. Disabling encephalopathy during 5-fluorouracil and levamisole adjuvant therapy for resected colorectal cancer: a report of two cases. Cancer Invest 13 (1995) 608-611
16. Fournier E., Passirani C., Montero-Menei C., Colin N., Breton P., Sagodira S., et al. Therapeutic effectiveness of novel 5-fluorouracil-loaded poly(methylidene malonate 2.1.2)-based microspheres on F98 glioma-bearing rats. Cancer 97 (2003) 2822-2829
17. Gomez-Pinilla F., Lee J.W., and Cotman C.W. Basic FGF in adult rat brain: cellular distribution and response to entorhinal lesion and fimbria-fornix transection. J Neurosci 12 (1992) 345-355
18. Hook C.C., Kimmel D.W., Kvols L.K., Scheithauer B.W., Forsyth P.A., Rubin J., et al. Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol 31 (1992) 262-267
19. Hua Y., Keep R.F., Schallert T., Hoff J.T., and Xi G. A thrombin inhibitor reduces brain edema, glioma mass and neurological deficits in a rat glioma model. Acta Neurochir Suppl 86 (2003) 503-506
20. Hua Y., Tang L., Keep R.F., Schallert T., Fewel M.E., Muraszko K.M., et al. The role of thrombin in gliomas. J Thromb Haemost 3 (2005) 1917-1923
21. Kaur B., Khwaja F.W., Severson E.A., Matheny S.L., Brat D.J., and Van Meir E.G. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro-oncol 7 (2005) 134-153
22. Keyvani K., and Schallert T. Plasticity-associated molecular and structural events in the injured brain. J Neuropathol Exp Neurol 61 (2002) 831-840
23. Krum J.M., and Khaibullina A. Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: roles for VEGF in brain repair. Exp Neurol 181 (2003) 241-257
24. Lemaire L., Roullin V.G., Franconi F., Venier-Julienne M.C., Menei P., Jallet P., et al. Therapeutic efficacy of 5-fluorouracil-loaded microspheres on rat glioma: a magnetic resonance imaging study. NMR Biomed 14 (2001) 360-366
25. Lu D., Goussev A., Chen J., Pannu P., Li Y., Mahmood A., et al. Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury. J Neurotrauma 21 (2004) 21-32
26. Lu D., Mahmood A., Qu C., Goussev A., Schallert T., and Chopp M. Erythropoietin enhances neurogenesis and restores spatial memory in rats after TBI. J Neurotrauma 22 (2005) 1011-1017
27. Macdonald D.R. Neurologic complications of chemotherapy. Neurol Clin 9 (1991) 955-967
28. Mattson M.P., Culmsee C., Slevin J.R., and Liu D. Synaptic apoptosis and neuroprotective strategies. In: Krieglstein J., and Klumpp S. (Eds). Pharmacology of Cerebral Ischemia (2002), Medpharm Scientific Publishers, Stuttgart 419-429
29. Menei P., Boisdron-Celle M., Croue A., Guy G., and Benoit J.P. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. Neurosurgery 39 (1996) 117-123
30. Menei P., Jadaud E., Faisant N., Boisdron-Celle M., Michalak S., Fournier D., et al. Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma. Cancer 100 (2004) 405-410
31. Monje M.L., and Palmer T. Radiation injury and neurogenesis. Curr Opin Neurol 16 (2003) 129-134
32. Neuwelt E.A., Barnett P.A., Glasberg M., and Frenkel E.P. Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies. Ann Neurol 14 (1983) 316-324
33. Neuwelt E.A., Barnett P.A., Glasberg M., and Frenkel E.P. Pharmacology and neurotoxicity of cis-diamminedichloroplatinum, bleomycin, 5-fluorouracil, and cyclophosphamide administration following osmotic blood-brain barrier modification. Cancer Res 43 (1983) 5278-5285
34. Nudo R.J., Wise B.M., Sifuentes F., and Milliken G.W. Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science 272 (1996) 1791-1794
35. Okeda R., Karakama T., Kimura S., Toizumi S., Mitsushima T., and Yokoyama Y. Neuropathologic study on chronic neurotoxicity of 5-fluorouracil and its masked compounds in dogs. Acta Neuropathol (Berl) 63 (1984) 334-343
36. Okeda R., Shibutani M., Matsuo T., and Kuroiwa T. Subacute neurotoxicity of 5-fluorouracil and its derivative, carmofur, in cats. Acta Pathol Jpn 38 (1988) 1255-1266
37. Okeda R., Shibutani M., Matsuo T., Kuroiwa T., Shimokawa R., and Tajima T. Experimental neurotoxicity of 5-fluorouracil and its derivatives is due to poisoning by the monofluorinated organic metabolites, monofluoroacetic acid and alpha-fluoro-beta-alanine. Acta Neuropathol (Berl) 81 (1990) 66-73
38. Parent J.M., Vexler Z.S., Gong C., Derugin N., and Ferriero D.M. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann Neurol 52 (2002) 802-813
39. Pirzada N.A., Ali I.I., and Dafer R.M. Fluorouracil-induced neurotoxicity. Ann Pharmacother 34 (2000) 35-38
40. Raber J., Fan Y., Matsumori Y., Liu Z., Weinstein P.R., Fike J.R., et al. Irradiation attenuates neurogenesis and exacerbates ischemia-induced deficits. Ann Neurol 55 (2004) 381-389
41. Rege T.A., Fears C.Y., and Gladson C.L. Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy. Neuro-oncol 7 (2005) 106-121
42. Schallert T., and Woodlee M.T. Motor systems: orienting and placing. In: Whishaw I.Q., and Kolb B. (Eds). The Behavior of the Laboratory Rat: A Hand Book with Tests (2005), Oxford University Press, New York 129-140
43. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39 (2000) 777-787
44. Schallert T., Woodlee M.T., and Fleming S.M. Disentangling multiple types of recovery from brain injury. In: Krieglstein J., and Klumpp S. (Eds). Pharmacology of Cerebral Ischemia (2002), Medpharm Scientific Publishers, Stuttgart 201-216
45. Seyfried D., Han Y., Lu D., Chen J., Bydon A., and Chopp M. Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats. J Neurosurg 101 (2004) 104-107
46. Shapiro W.R., and Young D.F. Neurological complications of antineoplastic therapy. Acta Neurol Scand Suppl 100 (1984) 125-132
47. Singh S.K., Clarke I.D., Hide T., and Dirks P.B. Cancer stem cells in nervous system tumors. Oncogene 23 (2004) 7267-7273
48. Vigliani M.C., Duyckaerts C., Hauw J.J., Poisson M., Magdelenat H., and Delattre J.Y. Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy: a clinical and pathological study. J Neurooncol 41 (1999) 137-149
49. Wang L., Zhang Z., Wang Y., Zhang R., and Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35 (2004) 1732-1737
50. Woodlee M.T., Asseo-Garcia A.M., Zhao X., Liu S.J., Jones T.A., and Schallert T. Testing forelimb placing "across the midline" reveals distinct, lesion-dependent patterns of recovery in rats. Exp Neurol 191 (2005) 310-317
51. Yang H, Preston M, Chopp M, Jiang F, Zhang X, Schallert T. Mass-related traumatic tissue displacement and behavior: a screen for treatments that reduce harm to bystander cells and recovery of function. J Neurotrauma, in press.
52. Yang H, Chopp M, Jiang F, Zhang X, Schallert T. Interruption of functional recovery by the NMDA glutamate antagonist MK-801 after compression of the sensorimotor cortex: implications for treatment of tumors or other mass-related brain injuries. Exp Neurol, 2006 Apr 17; [Epub ahead of print].
53. Zhang L., Zhang R.L., Wang Y., Zhang C., Zhang Z.G., Meng H., et al. Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor. Stroke 36 (2005) 847-852
54. Zhang R., Wang Y., Zhang L., Zhang Z., Tsang W., Lu M., et al. Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke 33 (2002) 2675-2680
55. Zhang R.W., Soong S.J., Liu T.P., Barnes S., and Diasio S.B. Pharmacokinetics and tissue distribution of 2-fluoro-beta-alanine in rats. Potential relevance to toxicity pattern of 5-fluorouracil. Drug Metab Dispos 20 (1992) 113-119